SCHEMBL14748486

SCHEMBL14748486

NN1CCC2(CC1)CN(C(=O)OCc1ccccc1)C2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ENPP2 Q13822 7/20 0.55
▸ ATXN2 Q99700 7/20 0.55
▸ MEN1 O00255 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.53
▸ SMN1; SMN2 Q16637 3/20 0.53
▸ CYP2C19 P33261 2/20 0.53
▸ NPC1 O15118 3/20 0.52
▸ RAB9A P51151 3/20 0.52
▸ ACACB O00763 1/20 0.47
▸ OPRD1 P41143 1/20 0.47
▸ OPRK1 P41145 1/20 0.47
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ KDM1A O60341 1/20 0.44
▸ JAK2 O60674 1/20 0.44
▸ JAK1 P23458 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25935199 0.89 ENPP2 (0.58) ENPP2ATXN2MEN1KMT2ANPSR1
SCHEMBL30121535 0.88 ENPP2 (0.62) ENPP2ATXN2MEN1KMT2ANPSR1
SCHEMBL14731552 0.88 ENPP2 (0.59) ENPP2ATXN2MEN1KMT2ANPSR1
SCHEMBL25376016 0.86 ENPP2 (0.55) ENPP2ATXN2MEN1KMT2ANPSR1
SCHEMBL10082704 0.85 ENPP2 (0.58) ENPP2ATXN2MEN1KMT2ANPSR1
SCHEMBL19633325 0.84 ENPP2 (0.53) ENPP2ATXN2MEN1KMT2ANPSR1
SCHEMBL1675680 0.83 MEN1 (0.66) MEN1KMT2ANPSR1SMN1; SMN2CYP2C19
SCHEMBL20669160 0.83 ENPP2 (0.60) ENPP2ATXN2MEN1KMT2ANPSR1
SCHEMBL30746332 0.82 MEN1 (0.51) ENPP2ATXN2MEN1KMT2ANPSR1
SCHEMBL7711512 0.82 ENPP2 (0.54) ENPP2ATXN2MEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2565194-A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE Astellas Pharma Inc. (JP) 2013-03-06 — — EP disclosed
Send feedback